• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Scarring Alopecia Under Immune Checkpoint Blockade: a Report of Three Cases.

作者信息

Braasch Sonja, Weishaupt Carsten, Spukti Eva, Böhm Markus, Braun Stephan Alexander

机构信息

Department of Dermatology, University Hospital Münster, Von-Esmarch-Str. 58, DE-48149 Münster, Germany.

出版信息

Acta Derm Venereol. 2022 Oct 11;102:adv00792. doi: 10.2340/actadv.v102.2311.

DOI:10.2340/actadv.v102.2311
PMID:36065744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9677265/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a06f/9677265/242c73915e6d/ActaDV-102-2311-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a06f/9677265/5b5251fb3df0/ActaDV-102-2311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a06f/9677265/242c73915e6d/ActaDV-102-2311-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a06f/9677265/5b5251fb3df0/ActaDV-102-2311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a06f/9677265/242c73915e6d/ActaDV-102-2311-g002.jpg

相似文献

1
Scarring Alopecia Under Immune Checkpoint Blockade: a Report of Three Cases.免疫检查点阻断治疗下的瘢痕性脱发：三例报告
Acta Derm Venereol. 2022 Oct 11;102:adv00792. doi: 10.2340/actadv.v102.2311.
2
Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors.斑秃作为一种与免疫检查点抑制剂反应相关的免疫相关不良事件。
Eur J Dermatol. 2022 Jul 1;32(4):546-548. doi: 10.1684/ejd.2022.4315.
3
Tofacitinib therapy for alopecia areata is not associated with adverse events during COVID-19 infection.托法替布治疗斑秃与 COVID-19 感染期间的不良事件无关。
J Am Acad Dermatol. 2023 May;88(5):1125-1127. doi: 10.1016/j.jaad.2022.05.005. Epub 2022 May 10.
4
An open-label study evaluating the efficacy of abatacept in alopecia areata.一项评估阿巴西普治疗斑秃疗效的开放标签研究。
J Am Acad Dermatol. 2021 Mar;84(3):841-844. doi: 10.1016/j.jaad.2020.09.091. Epub 2020 Oct 9.
5
Alopecia areata as an immune-related adverse event of immune checkpoint inhibitors: A review.斑秃作为免疫检查点抑制剂的免疫相关不良事件：综述
Dermatol Ther. 2020 Nov;33(6):e14171. doi: 10.1111/dth.14171. Epub 2020 Sep 7.
6
Alopecia areata masquerading as frontal fibrosing alopecia.伪装成额部纤维性脱发的斑秃
Australas J Dermatol. 2006 Feb;47(1):63-6. doi: 10.1111/j.1440-0960.2006.00227.x.
7
Development of alopecia areata during phosphodiesterase 4 inhibitor treatment for psoriasis: A case report.
Dermatol Ther. 2020 Nov;33(6):e14440. doi: 10.1111/dth.14440. Epub 2020 Nov 16.
8
Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis.外用2%托法替布治疗斑秃、全秃和普秃儿童。
J Am Acad Dermatol. 2018 Jun;78(6):1207-1209.e1. doi: 10.1016/j.jaad.2018.02.031.
9
Alopecia Areata after Omalizumab Treatment for Chronic Spontaneous Urticaria.
Acta Derm Venereol. 2019 Sep 1;99(10):919-920. doi: 10.2340/00015555-3244.
10
Bitemporal alopecia areata.双侧斑秃。
Australas J Dermatol. 2020 Aug;61(3):263-265. doi: 10.1111/ajd.13270. Epub 2020 Mar 5.

引用本文的文献

1
Scarring alopecia as an unexpected consequence of immune checkpoint inhibition.瘢痕性脱发作为免疫检查点抑制的意外后果。
JAAD Case Rep. 2025 May 8;61:1-6. doi: 10.1016/j.jdcr.2025.04.007. eCollection 2025 Jul.

本文引用的文献

1
Hair follicle immune privilege and its collapse in alopecia areata.毛发滤泡免疫豁免及其在斑秃中的崩溃。
Exp Dermatol. 2020 Aug;29(8):703-725. doi: 10.1111/exd.14155.
2
Medical therapy for frontal fibrosing alopecia: A review and clinical approach.额部纤维性脱发的医学治疗：综述与临床方法。
J Am Acad Dermatol. 2019 Aug;81(2):568-580. doi: 10.1016/j.jaad.2019.03.079. Epub 2019 Apr 3.
3
Nivolumab-induced alopecia areata: A reversible factor of good prognosis?纳武单抗诱导的斑秃：预后良好的可逆因素？
JAAD Case Rep. 2018 Sep 14;4(8):761-765. doi: 10.1016/j.jdcr.2018.05.022. eCollection 2018 Sep.
4
Lichen planopilaris associated with pembrolizumab in a patient with metastatic melanoma.一名转移性黑色素瘤患者中与帕博利珠单抗相关的扁平苔藓样毛发角化病。
JAAD Case Rep. 2018 Jan 16;4(2):132-134. doi: 10.1016/j.jdcr.2017.12.002. eCollection 2018 Mar.
5
Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors.接受免疫检查点抑制剂治疗的癌症患者中的免疫相关性脱发（斑秃和全秃）
Br J Dermatol. 2017 Jun;176(6):1649-1652. doi: 10.1111/bjd.15237. Epub 2017 Apr 24.
6
Primary cicatricial alopecia: Lymphocytic primary cicatricial alopecias, including chronic cutaneous lupus erythematosus, lichen planopilaris, frontal fibrosing alopecia, and Graham-Little syndrome.原发性瘢痕性脱发：淋巴细胞性原发性瘢痕性脱发，包括慢性皮肤型红斑狼疮、扁平苔藓样瘢痕性脱发、额部纤维性脱发和格雷厄姆-利特尔综合征。
J Am Acad Dermatol. 2016 Dec;75(6):1081-1099. doi: 10.1016/j.jaad.2014.09.058.
7
Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor.针对程序性死亡受体-1（PD-1）受体的药物所致皮肤不良事件的特征与管理
Eur J Cancer. 2016 Jun;60:12-25. doi: 10.1016/j.ejca.2016.02.010. Epub 2016 Apr 1.
8
Pembrolizumab versus Ipilimumab in Advanced Melanoma.帕博利珠单抗对比伊匹单抗用于晚期黑色素瘤。
N Engl J Med. 2015 Jun 25;372(26):2521-32. doi: 10.1056/NEJMoa1503093. Epub 2015 Apr 19.
9
Nivolumab in previously untreated melanoma without BRAF mutation.纳武利尤单抗治疗未经 BRAF 突变检测的初治黑色素瘤。
N Engl J Med. 2015 Jan 22;372(4):320-30. doi: 10.1056/NEJMoa1412082. Epub 2014 Nov 16.
10
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.抗 PD-1 抗体在癌症中的安全性、活性和免疫相关性。
N Engl J Med. 2012 Jun 28;366(26):2443-54. doi: 10.1056/NEJMoa1200690. Epub 2012 Jun 2.